Table 1.

Summary of statistical results

FigureStatistical test usedMain effectsPost hoc (LSD test)
Figure 2C Across frequenciesTwo-way RM ANOVALocation: F(1,24) = 3.261; p = 0.0835Frequency: F(29,696) = 2.400; p < 0.0001Location × frequency: F(29,696) = 0.6265; p = 0.9383
Figure 2D, δPaired t testt(12) = 2.580, p = 0.02
Figure 2E, θPaired t testt(12) = 1.934, p = 0.08
Figure 2F, βPaired t testt(12) = 1.639, p = 0.13
Figure 3C, δUnpaired t testt(11) = 2.353, p = 0.04
Figure 3D, θUnpaired t testt(11) = 1.264, p = 0.23
Figure 3E, % time in nestUnpaired t testt(11) = 0.09022, p = 0.9297
Figure 3F, % time nipple-attachedUnpaired t testt(10) = 0.4373, p = 0.6712
Figure 4C, δOne-way ANOVAF(3,12) = 4.704, p = 0.0215SAL-FLX vs SAL-SAL: p = 0.012SAL-FLX vs KET-FLX: p = 0.008SAL-FLX vs KET-SAL: p = 0.010SAL-SAL vs KET-FLX: p = 0.829SAL-SAL vs KET-SAL: p = 0.920KET-FLX vs KET-SAL: p = 0.908
Figure 4E, USVsOne-way ANOVAF(3,20) = 2.039, p = 0.1407
  • SAL = saline, FLX = fluoxetine, KET = ketanserin.